XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Assets:    
Cash and cash equivalents $ 10,081 $ 5,683
Investments 2,632 2,373
Accounts receivable, net 23,037 19,617
Inventories 16,976 17,516
Other current assets 6,232 5,113
Total current assets 58,958 50,302
Long-term investments 16,840 17,314
Property and equipment, net 12,146 12,044
Operating lease right-of-use assets 20,672 20,860
Goodwill 79,993 79,749
Intangible assets, net 32,727 33,121
Separate accounts assets 4,555 4,459
Other assets 4,748 4,600
Total assets 230,639 222,449
Liabilities:    
Accounts payable 10,223 10,492
Pharmacy claims and discounts payable 15,449 13,601
Health care costs payable 7,585 6,879
Policyholders’ funds 3,110 2,991
Accrued expenses 13,574 12,133
Other insurance liabilities 1,774 1,830
Current portion of operating lease liabilities 1,762 1,596
Short-term debt 255 0
Current portion of long-term debt 5,828 3,781
Total current liabilities 59,560 53,303
Long-term operating lease liabilities 18,739 18,926
Long-term debt 65,735 64,699
Deferred income taxes 7,121 7,294
Separate accounts liabilities 4,555 4,459
Other long-term insurance liabilities 7,338 7,436
Other long-term liabilities 2,117 2,162
Total liabilities 165,165 158,279
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,729 shares issued and 1,305 shares outstanding at March 31, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus 46,180 45,972
Treasury stock, at cost: 424 shares at March 31, 2020 and 425 shares at December 31, 2019 (28,182) (28,235)
Retained earnings 46,455 45,108
Accumulated other comprehensive income 687 1,019
Total CVS Health shareholders’ equity 65,140 63,864
Noncontrolling interests 334 306
Total shareholders’ equity 65,474 64,170
Total liabilities and shareholders’ equity $ 230,639 $ 222,449